MetaCap

Bio Green Med Solution (BGMS) vs Processa Pharmaceuticals (PCSA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Processa Pharmaceuticals is the larger company by market cap ($4.4 million vs $3.7 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BGMS-34.94%PCSA+9.86%
+41%+1%-39%
Oct 7, 20261 yearNov 20, 2026
BGMS-34.86%PCSA+2.63%
+30%-4%-38%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BGMS versus PCSA key metrics
MetricBGMSPCSA
Share price$0.553$1.56
Market cap$3.66M$4.37M
1-day change-9.48%-7.69%
EPS (TTM)$-3.78$-68.29
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$0—
Revenue growth (YoY)-100.00%—
Net income (latest FY)$-3.00M$-13.56M
52-week high$2.80$8.88
52-week low$0.55$1.04
Distance from 52-week high-80.25%-82.43%
Average volume76.12K79.50K
Shares outstanding6.62M2.80M
Employees—12
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Bio Green Med Solution

BGMS stock →

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.

Health Care · Biotechnology: Pharmaceutical Preparations

About Processa Pharmaceuticals

PCSA stock →

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.

Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees

BGMS vs PCSA FAQ

Which is bigger, Bio Green Med Solution or Processa Pharmaceuticals?

Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $4.37M compared with $3.66M for Bio Green Med Solution (BGMS).

Are Bio Green Med Solution and Processa Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons